LncRNA HOST2 enhances gefitinib-resistance in non-small cell lung cancer by down-regulating miRNA-621.
CONCLUSIONS: HOST2 elevates gefitinib-resistance in NSCLC by degrading miRNA-621 to upregulate SYF2.
PMID: 31799663 [PubMed - in process]
Source: European Review for Medical and Pharmacological Sciences - Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research
More News: Cancer | Cancer & Oncology | Drugs & Pharmacology | Genetics | Lung Cancer | Non-Small Cell Lung Cancer | Ovarian Cancer | Ovaries | Study